ETN vs MRK: Which Is the Better Buy?

Side-by-side comparison of Eaton Corporation plc and Merck & Co., Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Eaton Corporation plc ยท Industrials
$438.76
+32.2% upside to fair value
Med Conviction Grade B High Quality
VS
Merck & Co., Inc. ยท Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
QuantHub Verdict
ETN has more upside to fair value (+32.2%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ETN MRK
Current Price $438.76 $147.17
Fair Value Estimate $579.99 $141.07
Upside to Fair Value +32.2% -4.1%
Market Cap $170.4B $363.5B
Forward P/E โ€” โ€”
EV / EBITDA 29.6x 29.6x
Price / Sales 5.7x 5.5x
Price / FCF 37.9x 22.6x
Revenue Growth YoY +21.4% +5.1%
Gross Margin 35.9% 75.4%
Operating Margin 17.7% 16.7%
Return on Equity 19.6% 6.6%
Dividend Yield 0.99% 2.31%
FCF Yield 2.64% 4.42%
Analyst Consensus Strong Buy Buy
Investment Thesis
ETN โ€” Eaton Corporation plc
Eaton Corporation plc is a Dublin-headquartered power management company with roughly 97,303 employees, operating electrical, aerospace, vehicle and eMobility segments that supply power distribution, circuit protection, power quality and reliability equipment and services. The business quality is high: TTM gross margin of 35.9%, TTM operating margin of 17.7%, TTM net margin of 12.8% and ROE of 19โ€ฆ
MRK โ€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely higโ€ฆ
Accumulation Zones
Metric ETN MRK
Zone Low $434.99 $105.80
Zone High $492.99 $119.91
In Buy Zone? Yes No
โ† ETN Research    MRK Research โ†’    All Research